Bridgewater Associates’s Mesa Laboratories MLAB Stock Holding History

Bridgewater Associates’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,275	Closed	-$1.1M	–	745
2023 Q1	$1.1M	Buy	6,275 +239	+4%	+$42.8K	0.01%	553
2022 Q4	$1M	Sell	6,036 -2,029	-25%	-$318K	0.01%	644
2022 Q3	$1.14M	Buy	8,065 +88	+1%	+$16.1K	0.01%	679
2022 Q2	$1.63M	Buy	7,977 +732	+10%	+$160K	0.01%	717
2022 Q1	$1.85M	Buy	7,245 +1,707	+31%	+$464K	0.01%	699
2021 Q4	$1.82M	Buy	5,538 +451	+9%	+$142K	0.01%	476
2021 Q3	$1.54M	Sell	5,087 -246	-5%	-$69.9K	0.01%	467
2021 Q2	$1.45M	Buy	+5,333	New	+$1.35M	0.01%	537

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bridgewater Associates's MLAB Position: Q2 2023 in Review

Bridgewater Associates sold out of Mesa Laboratories (MLAB) in Q2 2023, closing a stake of 6,275 shares — an estimated $1.1M sold.

Bridgewater Associates first reported a position in MLAB in Q2 2021 and held it in 8 quarters. The position peaked at $1.85M in Q1 2022. 161 funds tracked by Wall St. Rank hold MLAB as of Q2 2023.

Bridgewater Associates reported no remaining Mesa Laboratories position as of Q2 2023 after selling out during the quarter.
Bridgewater Associates sold 6,275 Mesa Laboratories shares in Q2 2023, an estimated $1.1M.
Bridgewater Associates first reported a position in Mesa Laboratories in Q2 2021 and held it in 8 quarters.
Bridgewater Associates's Mesa Laboratories position peaked at $1.85M in Q1 2022.
161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2023.

Based on Bridgewater Associates's 13F filing for Q2 2023, filed 11 Aug 2023.